Bioray Biotech Co., Ltd
7561
Rank in Stocks
#27603
Bioray Biotech Co., Ltd is dedicated to the innovation, manufacturing, and... Bioray Biotech Co., Ltd is dedicated to the innovation, manufacturing, and distribution of biological and health supplement products. The company's biological offerings span specialized functional probiotics, therapeutic fungi, and immune cell preparations. Additionally, Bioray Biotech extends its expertise to the field of cellular testing and preservation services. Founded in 1994, this Taiwanese firm is based in Pingtung.
Share Price
$0.48470289
Last synced: 2026-11-10
Market Cap
$14.34M
Change (1 day)
-2.45%
Change (1 year)
-28.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bioray Biotech Co., Ltd (7561)
Category
Healthcare
Operating Margin for Bioray Biotech Co., Ltd (7561)
Operating Margin as of November 2026 TTM: 9.74%
According to Bioray Biotech Co., Ltd's latest financial reports, its current operating margin (TTM) is 9.74%. At the end of 2025 the company had an operating margin of 17.01%.
Operating Margin history for Bioray Biotech Co., Ltd from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 9.74% | -42.74% |
| 2025 | 17.01% | -894.86% |
| 2024 | -2.14% | -78.77% |
| 2023 | -10.08% | 8,300.00% |
| 2022 | -0.12% | -97.81% |
| 2021 | -5.48% | 3,814.29% |
| 2020 | -0.14% | -103.72% |
| 2019 | 3.76% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.01% |
DE
|
|
| 19.68% | -97.98% |
DE
|
|
| 13.26% | -98.64% |
JP
|
|
| 17.08% | -98.25% |
CH
|
|
| 14.92% | -98.47% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bioray Biotech Co., Ltd's operating margin
What is Bioray Biotech Co., Ltd's operating margin?
Bioray Biotech Co., Ltd's operating margin is 9.74%, as of Nov 2026.
What was Bioray Biotech Co., Ltd's operating margin in 2025?
In 2025, Bioray Biotech Co., Ltd's operating margin was 17.01%, compared with -2.14% in 2024.
How has Bioray Biotech Co., Ltd's operating margin changed since 2020?
From 2020 to 2025, Bioray Biotech Co., Ltd's operating margin was highest in 2025 (17.01%) and lowest in 2023 (-10.08%).
How does Bioray Biotech Co., Ltd's operating margin compare with similar companies?
Bioray Biotech Co., Ltd's operating margin (9.74%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.